Neurosoft Bioelectronics logo — Soft Minimally Invasive Brain Computer Interfaces

Neurosoft Bioelectronics

Soft Minimally Invasive Brain Computer Interfaces

Founded 2020 Switzerland Geneva, Switzerland 18 employees Seed Total: $10.46M Health Care, Medical Devices

General Information

Company Name Neurosoft Bioelectronics
Founded Year 2020
Location Switzerland Geneva, Switzerland +1
Employees 18
Industries Health Care, Medical Devices
Funding Stage Seed
Social

Get notified when Neurosoft Bioelectronics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Neurosoft Bioelectronics

Neurosoft Bioelectronics is pioneering the development of soft implantable brain computer interfaces with the slogan "Soft implantable brain computer interfaces". The company was founded in 2019 and is headquartered in Switzerland. Their focus on the Health Care industry aligns with their mission to enhance patient care for individuals suffering from neurological disorders. At the core of their innovation is the creation of soft implantable electrodes designed to interface with the nervous system. The unique technology developed by Neurosoft Bioelectronics enables the production of highly compliant neural interfaces, allowing for long-term bio-integration within the body. This breakthrough opens up new therapeutic possibilities, ultimately improving patient outcomes. Their latest milestone, a grant investment received on 28 April 2023 from Innosuisse, signifies a strong validation of their groundbreaking work. Neurosoft Bioelectronics is poised to make significant contributions in the field of neurological treatment with their innovative approach to neural interfaces.

Taxonomy: Neurology, Neurological disorders, Brain computer interfaces, Implantable electrodes, Bio-integration, Neural interfaces, Medical technology, Neurological care, Therapeutic outcomes, Bioelectronics

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Seed •••••• 4
Investor Investor Investor
•••• ••••
20 May 2026
Grant •••••• 1
Investor
28 Apr 2023
Grant •••••• 1
Investor
29 Mar 2022
Convertible Note •••••• 1 •••• •••• 17 Dec 2021
Seed Round •••••• 1
Investor
28 Jan 2021

View All 8 Funding Rounds

Neurosoft Bioelectronics Alternatives & Competitors

Neurosoft Bioelectronics vs
Afference, Inc.
Afference, Inc. United States

Powering the sense of touch in the digital world.

Seed
12 employees
Hardware, Manufacturing
Neurosoft Bioelectronics vs
H+
H+ United Kingdom

On neural interfaces, AR, biohacking, bionic prosthetics, genetic engineering, tissue engineering, w...

2 employees
AI, VR/AR
Neurosoft Bioelectronics vs

Brain interfaces for better health: Scientifically grounded. Technically ambitious.

11 employees
Biotechnology, Health Care
Also compare with: Neurosoft Bioelectronics vs Neuralink Neuralink

FAQ About Neurosoft Bioelectronics

Soft Minimally Invasive Brain Computer Interfaces
Neurosoft Bioelectronics was founded in 2020.
Neurosoft Bioelectronics is headquartered in Geneva, Switzerland.
Neurosoft Bioelectronics operates in the following industries: Health Care, Medical Devices.
Neurosoft Bioelectronics has approximately 18 employees.
Neurosoft Bioelectronics has completed 8 funding rounds, raising a total of $10.46M. The latest funding stage is Seed.
Top alternatives and competitors to Neurosoft Bioelectronics include Afference, Inc., H+, Starfish Neuroscience, Wispr AI, Neuralink. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Neurosoft Bioelectronics and Afference, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Neurosoft Bioelectronics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes